文献速递放疗物理与技术中枢神经肿瘤放疗头颈部肿瘤放疗

MedAustron碳离子放疗危及器官剂量约束:LEM与MKM相对生物效应模型间的转换及初步临床结果

Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results.
PubMed 文献 · Radiother Oncol · 2022-08-08

研究分析31例在MedAustron接受碳离子放疗患者的LEM计划,用RayStation v9A重算为MKM并提取脑实质、脑干和视路剂量统计,拟合出线性二次转换模型;当前LEM约束与推荐MKM约束偏差在-8%至+3.9%之间,个别离群病例出现影像学无症状毒性。

要点

  • 31例CIRT患者LEM计划重算为MKM,脑实质、脑干和视路剂量偏差在-8%至+3.9%之间。
  • 当前LEM约束与推荐MKM约束总体匹配,但个别病例偏离趋势形成离群值。
  • 2例离群病例检出影像学无症状毒性,遵守LEM约束不保证满足MKM约束。

核心结论

  • 遵守LEM约束并不自动确保满足MKM约束,未来MedAustron的CIRT患者需同时满足两种RBE模型的约束。
  • 仔细选择计划策略至关重要。

研究设计与样本

  • 研究纳入31例在MedAustron接受碳离子放疗的患者,使用RayStation v9A计划系统将临床LEM计划重算为MKM。
  • 提取脑实质、脑干和视路等关键危及器官的剂量统计(D1cm3、D5cm3、D0.1cm3、D0.7cm3、D10%、D20%),并进行曲线拟合得出线性二次转换模型。
  • 评估临床与影像学毒性。

主要发现

  • 基于推导拟合,当前应用的LEM约束与推荐MKM约束相匹配,偏差在-8%至+3.9%之间。
  • 特定病例数据未遵循预期的LEM与MKM趋势,形成离群值。
  • 2例离群病例检出影像学无症状毒性。

关键数值与推荐

  • 当前LEM约束与推荐MKM约束偏差范围为-8%至+3.9%。
  • 提取的剂量统计指标包括D1cm3、D5cm3、D0.1cm3、D0.7cm3、D10%、D20%。

临床怎么用

  • 未来MedAustron的CIRT患者需同时满足LEM和MKM两种RBE模型的约束。
  • 作者认为仔细选择计划策略至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbon ion radiotherapy (CIRT) treatment planning is based on relative biological effectiveness (RBE) weighted dose calculations. A large amount of clinical evidence for CIRT was collected in Japan with RBE estimated by the modified microdosimetric kinetic model (MKM) while all European centres apply the first version of the local effect model (LEM). Japanese schedules have been used in Europe with adapted prescription dose and organs at risk (OAR) dose constraints. Recently, less conservative adapted LEM constraints have been implemented in clinical practice. The aim of this study was to analyse the new set of LEM dose constraints for brain parenchyma, brainstem and optic system considering both RBE models and evaluating early clinical data. MATERIAL AND METHODS: 31 patients receiving CIRT at MedAustron were analysed using the RayStation v9A planning system by recalculating clinical LEM-based plans in MKM. Dose statistics (D1cm3, D5cm3, D0.1cm3, D0.7cm3, D10%, D20%) were extracted for relevant critical OARs. Curve fitting for those values was performed, resulting in linear quadratic translation models. Clinical and radiological toxicity was evaluated. RESULTS: Based on derived fits, currently applied LEM constraints matched recommended MKM constraints with deviations between -8% and +3.9%. For particular cases, data did not follow the expected LEM vs MKM trends resulting in outliers. Radiological (asymptomatic) toxicity was detected in two outlier cases. CONCLUSION: Respecting LEM constraints does not automatically ensure that MKM constraints are met. Constraints for both RBE models need to be fulfilled for future CIRT patients at MedAustron. Careful selection of planning strategies is essential.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Grosshagauer S, Fossati P, Schafasand M, et al. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results. Radiother Oncol. 2022. PMID: 35952977. doi:10.1016/j.radonc.2022.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。